Blog
12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution...
NIAID
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain - Blog
NIAID Researchers Find Anti-HIV Antibodies Affect Immune Responses When Delivered During Acute Infection 11-21-2024Cross-posted from: National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infe... - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients... - Blog
Defining the Goals of HIV Science Through 2034 10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical... - Blog
SARS-CoV-2 Rapidly Evolves in People with Advanced HIV 09-11-2024Cross-posted from: NIAID Now NIAID Researchers Uncover How SARS-CoV-2 Variants May Emerge in People with Weak... - Blog
ICYMI: Research Roundup from AIDS 2024 08-15-2024A brief roundup of key topics of HIV.gov s coverage of AIDS 2024, including HIV prevention, cure research, and more. - Blog
We Should Leverage the Successes of HIV Care to Prevent Overdose Mortality 08-01-2024Cross-posted from: NIDA blog For complex reasons, HIV and substance use have been inextricably linked since the... - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (teal) budding and... - Blog
An Emergency Department Screening Strategy Identifies Asymptomatic and Undiagnosed Syphilis 06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and treat… - Blog
FYI Video: A Conversation About the Importance of HIV Vaccine Research 06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for ontroll..… - Blog
NIAID Marks HIV Vaccine Awareness Day 2024 05-17-2024Cross-posted from: NIAID Now Vaccines consistently transform public health, and HIV vaccine research has been... - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.… - Blog
Resources for 2024 HIV Vaccine Awareness Day 05-14-2024Resources to highlight HIV Vaccine Awareness Day on May 18, a day to recognize the community members, health professionals, and scientists working together to d… - Blog
NIH Ending the HIV Epidemic Projects Bridge Gaps Between HIV Research and Public Health Practice (VIDEO) 04-09-2024Cross-posted from: NIAID Now Blog The National Institutes of Health recently issued $26M inawardsto... - Blog
Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV 03-06-2024Colorized transmission electron micrograph of two HIV-1 virus particles (red/yellow) budding from the plasma memb... - Blog
Children Surpass a Year of HIV Remission after Treatment Pause 03-06-2024Colorized transmission electron micrograph of HIV-1 virus particles (yellow) budding and replicating from an H9... - Blog
Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update from CROI 2024 03-06-2024On Tuesday at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with NIH s Dr. Carl Dieffenbach about research on common... - Blog
NIAID’s Dr. Jeanne Marrazzo Previews CROI 2024 03-04-2024HIV.gov opened our coverage of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) today with a conversation with Jeanne Marrazzo, M.D.,... - Blog
Follow HIV.gov Next Week: Key HIV Research Updates from CROI 2024 02-27-2024Next week, HIV.gov will be sharing updates on the latest HIV research from the 2024Conference on Retroviruses and Opportunistic Infections (CROI), taking... - Blog
Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed 02-22-2024Cross-posted from: NIAID Newsroom Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine...